Please use this identifier to cite or link to this item:
https://doi.org/10.1007/s12070-011-0258-y
DC Field | Value | |
---|---|---|
dc.title | The MicroFlow Spacer: A Drug-Eluting Stent for the Ethmoid Sinus | |
dc.contributor.author | Catalano, P.J. | |
dc.contributor.author | Thong, M. | |
dc.contributor.author | Weiss, R. | |
dc.contributor.author | Rimash, T. | |
dc.date.accessioned | 2016-07-08T09:28:59Z | |
dc.date.available | 2016-07-08T09:28:59Z | |
dc.date.issued | 2011-07 | |
dc.identifier.citation | Catalano, P.J., Thong, M., Weiss, R., Rimash, T. (2011-07). The MicroFlow Spacer: A Drug-Eluting Stent for the Ethmoid Sinus. Indian Journal of Otolaryngology and Head and Neck Surgery 63 (3) : 279-284. ScholarBank@NUS Repository. https://doi.org/10.1007/s12070-011-0258-y | |
dc.identifier.issn | 22313796 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/125591 | |
dc.description.abstract | To evaluate the short-term outcomes and safety of a newly introduced drug-eluting ethmoid stent. Prospective study of 23 patients with a total of 40 implanted ethmoid sinuses. Two tertiary care medical facility. Twenty-three patients with medically refractory chronic rhinosinusitis were treated with patient-appropriate endoscopic sinus surgery, with the modification of treating the ethmoid sinuses with an ethmoid stent infused with triamcinolone, instead of conventional endoscopic ethmoidectomy. Patients were then followed up over 6 months. Outcomes were assessed by interval changes in 20-item Sino-Nasal Outcome Test (SNOT-20) and Lund-MacKay CT scores. Safety was determined by adverse events. Overall, the pre-op SNOT-20 mean score was 2. 18, versus post-op score of 1. 02, an improvement of 1. 16 that was both statistically (P < 0. 001) and clinically significant. Ethmoid-specific and side-specific Lund-MacKay mean scores both also showed statistically significant improvements. Pre-op ethmoid-specific Lund-MacKay mean score was 1. 93, versus post-op score of 1. 10, an improvement of 0. 83 (P < 0. 001). Pre-op side-specific Lund-MacKay mean score was 5. 75, compared with post-op score of 2. 95, an improvement of 2. 80 (P < 0. 001). There were no significant intra-op or post-op complications encountered. This triamcinolone-infused ethmoid stent appears safe and effective in treating chronic ethmoid sinus disease within the defined follow-up period. The ability to deliver medication directly to diseased mucosa holds wide-ranging potential. © 2011 Association of Otolaryngologists of India. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1007/s12070-011-0258-y | |
dc.source | Scopus | |
dc.subject | Drug | |
dc.subject | Elution | |
dc.subject | Ethmoid | |
dc.subject | Sinus | |
dc.subject | Stent | |
dc.type | Article | |
dc.contributor.department | OTOLARYNGOLOGY | |
dc.description.doi | 10.1007/s12070-011-0258-y | |
dc.description.sourcetitle | Indian Journal of Otolaryngology and Head and Neck Surgery | |
dc.description.volume | 63 | |
dc.description.issue | 3 | |
dc.description.page | 279-284 | |
dc.description.coden | IONSF | |
dc.identifier.isiut | 000292886100017 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.